{
}
Macopharma Group has acquired Germany"s LMB Technologies in an all-share deal expected to close in early 2025, enhancing its control over the blood transfusion equipment market. This strategic move aims to consolidate market share in Europe and the Middle East while targeting expansion into the American and South American markets. With LMB"s innovative capabilities and a strong R&D presence, Macopharma plans to double its equipment sales and launch at least one patented product annually.
Gérard Mulliez
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Macopharma acquires LMB Technologies to enhance blood sector capabilities
15:00 19.11.2024
Trending
Subcategory
Industry Trends
Corporate News
Startups & Entrepreneurship
Global Trade Developments
Retail and Consumer Goods
Supply Chain Management
Stock Market Updates
Government Economic Policies
Industry Mergers & Acquisitions
Fintech Startups
Private Equity Deals
CEO Changes
Venture Capital Investments
AI Applications
Corporate Social Responsibility
AI Innovations
Funding Rounds & Investments
Economic Indicators
Market Analysis and Predictions
Emerging Startups
Countries:
Companies:
Apple Inc.
Grab2Go AS
Google Inc.
OLA ELECTRIC MOBILITY LTD
NVIDIA Corp
Amazon.com, Inc.
Microsoft Corporation
EFG Hermes Egypt
Broadcom Inc.
XIAOMI-W
Tesla, Inc.
LG CNS
Delhivery Limited
Ecom Express Ltd.
Scripbox.COM India Ltd.
SK hynix Inc.
Tesmec S.p.A.
OpenAI ERC USD
FTSE NASDAQ Dubai UAE 20 Index
The Goldman Sachs Group, Inc.
Currencies:
United States Dollar
Indian Rupee
Chinese Yuan
Euro
Japanese Yen
United Arab Emirates Dirham
South Korean Won
Pakistani Rupee
Egyptian Pound
Saudi Riyal
Brazilian Real
Qatari Riyal
Indonesian Rupiah
Vietnamese Đồng
Hong Kong Dollar
Offshore Chinese Yuan
Canadian Dollar
Malaysian Ringgit
People: